Two Authorized Studies Proved Again The Extraordinary Benefits on Pharmanex ReishiMax GLP

Two Authorized Studies Proved Again
The Extraordinary Benefits on Pharmanex ReishiMax GLP

In recent months, new and exciting research has been published in the area of cancer prevention and treatment with Ganoderma lucidum (reishi).

In a recently published study in the Journal of Alternative and Complementary Medicine, the biological activity of several reishi supplements, including Pharmanex ReishiMax GLP were compared to determine their ability to inhibit certain factors of highly invasive breast and prostate cancer cells. The study found the most potent inhibition against breast and prostate cancer cell proliferation in ReishiMax GLP. The article states, "Interestingly, the sample containing powdered extract with spores (ReishiMax GLP) was the most potent in inhibiting migration (99%)." The authors also noted that ReishiMax GLP was the only reishi product to identify standardized active constituents, and suggested that, "the difference in potency to inhibit cancer cells of the different samples of Ganoderma lucidum can be the result of variation in the concentration of the active ingredients."Lastly, the authors showed that cracking spores by mechanistic disruption (as with ReishiMax GLP), increased activity by releasing biologically active components.

A second study using ReishiMax GLP was just published in the Journal of Cancer Integrative Medicine. The authors concluded that Ganoderma lucidum might contribute to reducing invasion and metastasis of breast cancers by inhibiting cancer cell adhesion, cell migration, and growth of cancer cells. The study also showed that Ganoderma lucidum could have preventive effects against secondary metastases, which are responsible for the high mortality of breast cancer.

Reference

· Sliva D, Sedlak M, Slivova V, Valachovicova T, Lloyd FP Jr, Ho NW. Biologic activity of spores and dried powder from Ganoderma lucidum for the inhibition of highly invasive human breast and prostate cancer cells. J Altern Complement Med. 2003 Aug;9(4):491-7.

· Slivova V, Valachovicova T, Jiang J, Sliva D. Ganoderma lucidum inhibits invasiveness of breast cancer cells. J Int Med. 2004;2(1).

See also here

Beauty of Innovation
http://beautyofinnovation.multiply.com
Contact +63.927.724.6878 to inquire